Search for: "-DLB Hill v. Novartis Pharmaceuticals"
Results 1 - 19
of 19
Sorted by Relevance
|
Sort by Date
14 Aug 2013, 1:57 pm
Supp.2d 608, 615 (W.D.N.C. 2012); Hill v. [read post]
2 Jul 2013, 11:38 am
Novartis Pharmaceuticals Corp., No. 0:06-cv-61337-JIC (S.D. [read post]
5 Sep 2013, 10:40 pm
Speaking of India’s contentious compulsory licensing order in Natco v. [read post]
3 Nov 2010, 1:21 am
No – discussion of patent-eligibility standards for genes (Patent Baristas) US: Appellees file reply brief in Therasense v Becton Dickinson (Patent Docs) US: Another Capitol Hill missive objects to the inclusion of patent settlement provisions in FY 2011 Appropriations Bill (FDA Law Blog) US: REMS and 180-day exclusivity forfeiture – some interesting disclosures to the SEC (FDA Law Blog) Products Botox (Botulinum) – EU: General Court upholds opposition to BOTUMAX… [read post]
27 Mar 2012, 12:58 pm
Novartis Pharmaceutical Corp., 2012 U.S. [read post]
23 May 2013, 5:00 am
We read them – well at least Bexis does, because he has to update the evidentiary chapter for his book – but usually there’s not enough there there for a blogpostNot so with Hill v Novartis Pharmaceuticals Corp., ___ F. [read post]
30 Nov 2015, 1:25 pm
Novartis Pharmaceuticals Corp., 944 F. [read post]
11 Jul 2011, 4:47 pm
” The case of ILARIS “may be another trigger for a fix to the priority voucher program as part of the PDUFA V reauthorization negotiations on Capitol Hill,” says The RPM Report. [read post]
15 Feb 2013, 12:10 pm
Novartis Pharmaceuticals Corp., ___ Fed. [read post]
5 Sep 2013, 12:24 pm
This is an argument that the A/Z defense already won in Hill v Novartis Pharmaceuticals Corp., ___ F. [read post]
20 Mar 2009, 2:05 am
Novartis Pharmaceuticals Corp., 283 F.3d 254, 272 n.11 (5th Cir. 2002); Williams v. [read post]
2 Jun 2011, 12:46 pm
Novartis Pharmaceuticals Corp., 2011 WL 1533467, at *9 (E.D.N.Y. [read post]
12 Dec 2021, 2:22 pm
Novartis Pharms. [read post]
22 Aug 2014, 9:22 am
Novartis Pharmaceutical Corp., 2013 WL 4648449 (M.D. [read post]
3 Aug 2020, 7:02 am
Where there are specialists with a focus on the kind of work with which a patent is concerned, they are the relevant addressees of the patent and their specialist skills are attributed to the notional skilled person, even if the patent might also be of a broader application and of interest to non-specialists (Medimmune Ltd v Novartis Pharmaceuticals UK Ltd [2013] RPC 27). [read post]
2 Oct 2008, 12:36 pm
Novartis Pharmaceuticals Corp., 283 F.3d 254, 266-68 (5th Cir. 2002), where the court didn't let the plaintiff get away with arguing that there should have been a warning about "liver failure" and "death" in addition to "hepatitis. [read post]
15 Feb 2008, 9:00 am
A step behind: (Spicy IP),Proposals for ISPs to terminate infringers go (even more) global: (LawFont.com),Five ways to minimize risk of copyright liability from citizen media: (IP ADR Blog), Pharma & BiotechPharma & Biotech - GeneralMillennium Pharmaceuticals spent $1.28 million on lobbying for patent reform and biologics legislation in 2007: (Patent Docs),New Thai Minister may review compulsory licences on cancer drugs: (Intellectual Property… [read post]
8 Feb 2008, 7:00 pm
– Facebook’s contractual rights to users’ photos problematic: (Spicy IP)PharmaEuropean Commission probes pharmaceutical sector: (Philip Brooks),WHO Board sets course on IP, avian flu, tighter publication policy: (Intellectual Property Watch),India: The Competition Act, patents and over hyped drugs: (Part I - Spicy IP), (Part II – Spicy IP), (Part III – Spicy IP),Ignoring not the solution … [read post]
11 Sep 2013, 4:48 am
Novartis Pharmaceuticals Corp. [read post]
